GSEA showed that genes upregulated in aggressive and metastatic ccRCC were enriched in pathways associated with the immune response (Interferon (IFN)-γ response and allograft rejection) and cell cycle (E2F targets; Figure 7A). The gene discussed is IFNG; the disease is nonpapillary renal cell carcinoma.